Latest news
FDA approves new drug to help stop COVID-19 infection after exposure - WBAL-TVWBAL-TV · Tue, 04 Aug 2026 20:48:00 GMTShionogi (TSE:4507) Is Up 6.5% After U.S. Launch Of XOCOVA COVID Prophylaxis Drug – Has The Bull Case Changed? - simplywall.stsimplywall.st · Thu, 30 Jul 2026 08:36:24 GMTOral Antiviral Xocova Available for COVID-19 Postexposure Prophylaxis - MPR - Medical Professionals ReferenceMedical Professionals Reference · Tue, 28 Jul 2026 07:00:00 GMTEnsitrelvir now available in US for COVID-19 postexposure prophylaxis - contemporarypediatrics.comcontemporarypediatrics.com · Tue, 28 Jul 2026 07:00:00 GMT